Cardiovascular and metabolic effects of Berberine

被引:99
作者
Affuso, Flora [1 ]
Mercurio, Valentina [1 ]
Fazio, Valeria [1 ]
Fazio, Serafino [1 ]
机构
[1] Univ Naples Federico II, Sch Med, Dept Internal Med Cardiovasc & Immunol Sci, Via S Pansini 5, I-80131 Naples, Italy
关键词
Metabolic syndrome; Berberine; Adenosine monophosphate kinase; Insulin resistance; Hyperlipidemia; Endothelial function;
D O I
10.4330/wjc.v2.i4.71
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Berberine (BBR) is a natural alkaloid isolated from the Coptis Chinensis. While this plant has been used in Ayurvedic and Chinese medicine for more than 2500 years, interest in its effects in metabolic and cardiovascular disease has been growing in the Western world in the last decade. Many papers have been published in these years reporting beneficial effects in carbohydrate and lipid metabolism, endothelial function and the cardiovascular system. In this review, we report a detailed analysis of the scientific literature regarding this topic, describing the effects and the underlying mechanisms of BBR on carbohydrate and lipid metabolism, endothelial function and the cardiovascular system. (C) 2010 Baishideng. All rights reserved.
引用
收藏
页码:71 / 77
页数:7
相关论文
共 50 条
[1]
Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine [J].
Abidi, P ;
Zhou, Y ;
Jiang, JD ;
Liu, JW .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (10) :2170-2176
[2]
Affuso F, 2009, NUTR METAB CARDIOVAS
[3]
Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine [J].
Brusq, Jean-Marie ;
Ancellin, Nicolas ;
Grondin, Pascal ;
Guillard, Raphaelle ;
Martin, Sandrine ;
Saintillan, Yannick ;
Issandou, Marc .
JOURNAL OF LIPID RESEARCH, 2006, 47 (06) :1281-1288
[4]
Berberine decreases PCSK9 expression in HepG2 cells [J].
Cameron, Jamie ;
Ranheim, Trine ;
Kulseth, Mari Ann ;
Leren, Trond P. ;
Berge, Knut Erik .
ATHEROSCLEROSIS, 2008, 201 (02) :266-273
[5]
Atorvastatin increases human serum levels of proprotein convertase subtilisin/kexin type 9 [J].
Careskey, Holly E. ;
Davis, R. Aleks ;
Alborn, William E. ;
Troutt, Jason S. ;
Cao, Guoqing ;
Konrad, Robert J. .
JOURNAL OF LIPID RESEARCH, 2008, 49 (02) :394-398
[6]
Cicero AEG, 2007, ARZNEIMITTELFORSCH, V57, P26
[7]
The effect of AMP-activated protein kinase and its activator AICAR on the metabolism of human umbilical vein endothelial cells [J].
Dagher, Z ;
Ruderman, N ;
Tornheim, K ;
Ido, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 265 (01) :112-115
[8]
CPU86017: A novel class III antiarrhythmic agent with multiple actions at ion channels [J].
Dai, De-Zai .
CARDIOVASCULAR DRUG REVIEWS, 2006, 24 (02) :101-115
[9]
Endothelial dysfunction [J].
Endemann, DH ;
Schiffrin, EL .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (08) :1983-1992
[10]
Endothelial nitric oxide synthase in vascular disease -: From marvel to menace [J].
Förstermann, U ;
Münzel, T .
CIRCULATION, 2006, 113 (13) :1708-1714